Skip to main content


Fig. 2 | BMC Cancer

Fig. 2

From: Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma

Fig. 2

New yardstick for diagnosis and treatment assessment. Samples from individual who consult doctor are detected by various high-throughput techniques to achieve the personalized molecular information. Oral cancer patients will be diagnosed and healthy or other disease patients excluded by matching patient molecular alternation with various diagnosis models. According to the biomarker prediction models, oral cancer patients then could be evaluated and classified into most appropriate group to receive the most reasonable therapeutics

Back to article page